CUROCELL INC.;KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
发明人:
KIM, CHAN HYUK,LEE, YOUNG-HO,LEE, YUJEAN,LEE, HYEONGJI,LEE, SANG HOON
申请号：
CA3088234
公开号：
CA3088234A1
申请日:
2019.01.10
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present disclosure is broadly concerned with the field of cancer immunotherapy. For example, the present invention generally relates to an immune cell comprising a genetically engineered antigen receptor that specifically binds to a target antigen and a genetic disruption agent that reduces or is capable of reducing the expression in the immune cell of a gene that weakens the function of the immune cell.
